Virtu Financial LLC grew its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 85.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,699 shares of the insurance provider's stock after acquiring an additional 1,706 shares during the quarter. Virtu Financial LLC's holdings in Humana were worth $938,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors have also recently made changes to their positions in the company. FPC Investment Advisory Inc. bought a new stake in Humana during the fourth quarter worth $27,000. Centricity Wealth Management LLC purchased a new stake in shares of Humana during the 4th quarter valued at $30,000. LFA Lugano Financial Advisors SA raised its stake in shares of Humana by 56.3% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock worth $32,000 after purchasing an additional 45 shares during the period. OFI Invest Asset Management purchased a new position in shares of Humana in the 4th quarter worth about $33,000. Finally, Atwood & Palmer Inc. grew its position in Humana by 64.5% during the fourth quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider's stock valued at $39,000 after buying an additional 60 shares during the period. Institutional investors own 92.38% of the company's stock.
Analysts Set New Price Targets
A number of research analysts have weighed in on HUM shares. JPMorgan Chase & Co. dropped their target price on shares of Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a research note on Tuesday, February 18th. Truist Financial upped their price objective on Humana from $260.00 to $290.00 and gave the company a "hold" rating in a research note on Monday, January 6th. Piper Sandler raised their target price on Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a research report on Wednesday, January 15th. StockNews.com cut Humana from a "buy" rating to a "hold" rating in a research report on Tuesday, March 18th. Finally, Barclays lifted their price objective on Humana from $255.00 to $270.00 and gave the stock an "equal weight" rating in a report on Thursday, February 13th. Eighteen analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $285.68.
Check Out Our Latest Stock Report on Humana
Insiders Place Their Bets
In other news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares in the company, valued at approximately $2,096,463.06. This represents a 31.16 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.37% of the company's stock.
Humana Price Performance
NYSE HUM traded down $0.44 during trading on Thursday, reaching $270.04. The company's stock had a trading volume of 1,284,380 shares, compared to its average volume of 1,710,924. The firm has a fifty day moving average of $270.63 and a 200 day moving average of $274.97. Humana Inc. has a one year low of $213.31 and a one year high of $406.46. The stock has a market capitalization of $32.59 billion, a PE ratio of 27.14, a P/E/G ratio of 2.05 and a beta of 0.57. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76.
Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.
Humana Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a $0.885 dividend. The ex-dividend date is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a yield of 1.31%. Humana's dividend payout ratio is presently 35.58%.
Humana Company Profile
(
Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
See Also
Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
